NPT Co Ltd Sustainability Reports
The company engages in the clinical development of new drugs and treatments for personalized medicine based on genomic information, focusing on advanced research in cancer immunotherapy.
Sector: Manufacturing
Country: Japan
Exchange: Tokyo Stock Exchange
FIGI: BBG01RBHSW44
No reports are currently available in our catalogue.